{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:47:05Z","timestamp":1789501625346,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.prp.2024.155222","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T11:08:17Z","timestamp":1708686497000},"page":"155222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer"],"prefix":"10.1016","volume":"256","author":[{"given":"Shubham","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himani","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshav Raj","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amlan","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"MacLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2024.155222_bib1","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2174\/1871530320666200428113051","article-title":"MicroRNAs as biomarker for breast cancer","volume":"20","author":"Aggarwal","year":"2020","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.prp.2024.155222_bib2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature14281","article-title":"N 6-methyladenosine marks primary microRNAs for processing","volume":"519","author":"Alarc\u00f3n","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.prp.2024.155222_bib3","doi-asserted-by":"crossref","first-page":"19280","DOI":"10.1002\/jcp.28607","article-title":"The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy","volume":"234","author":"Alizadeh","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2024.155222_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/nano12234312","article-title":"Phytantriol-based berberine-loaded liquid crystalline nanoparticles attenuate inflammation and oxidative stress in lipopolysaccharide-induced RAW264.7 macrophages","volume":"12","author":"Alnuqaydan","year":"2022","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.prp.2024.155222_bib5","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1101\/gad.1705308","article-title":"Mouse ES cells express endogenous shRNAs, siRNAs, and other microprocessor-independent, Dicer-dependent small RNAs","volume":"22","author":"Babiarz","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2024.155222_bib6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PPO.0000000000000138","article-title":"The contribution of angiogenesis to the process of metastasis","volume":"21","author":"Bielenberg","year":"2015","journal-title":"Cancer J. (Sudbury, Mass.)"},{"key":"10.1016\/j.prp.2024.155222_bib7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nature09092","article-title":"A dicer-independent miRNA biogenesis pathway that requires Ago catalysis","volume":"465","author":"Cheloufi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.prp.2024.155222_bib8","article-title":"miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer","volume":"12","author":"Chen","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2024.155222_bib9","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/mt.2010.136","article-title":"Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy","volume":"18","author":"Chen","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.prp.2024.155222_bib10","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/2159-8290.CD-14-0337","article-title":"AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer","volume":"4","author":"Cross","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.prp.2024.155222_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110737","article-title":"Rubis, Emerging applications and prospects of NFkappaB decoy oligodeoxynucleotides in managing respiratory diseases","volume":"385","author":"Datsyuk","year":"2023","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.prp.2024.155222_bib12","first-page":"381","article-title":"Mechanisms of control of microRNA biogenesis","volume":"148","author":"Davis-Dusenbery","year":"2010","journal-title":"J. Biochem."},{"key":"10.1016\/j.prp.2024.155222_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.prp.2024.155222_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/978-3-030-74035-1_17","article-title":"Tea (catechins including (\u2212)-epigallocatechin-3-gallate) and cancer","author":"Devkota","year":"2021","journal-title":"Nutraceuticals Cancer Signal.: Clin. Asp. Mode Action"},{"key":"10.1016\/j.prp.2024.155222_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/ejh.12124","article-title":"Aberrant micro RNA expression in multiple myeloma","volume":"91","author":"Dimopoulos","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.prp.2024.155222_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs\u2014microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2024.155222_bib17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2024.155222_bib18","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1101\/gad.1262504","article-title":"The Drosha-DGCR8 complex in primary microRNA processing","volume":"18","author":"Han","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2024.155222_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1381612826666200728151610","article-title":"Targeting cancer using curcumin encapsulated vesicular drug delivery systems","volume":"27","author":"Hardwick","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.prp.2024.155222_bib20","first-page":"3959","article-title":"miR\u2011497 inhibits the proliferation and migration of A549 non\u2011small\u2011cell lung cancer cells by targeting FGFR1","volume":"20","author":"Huang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prp.2024.155222_bib21","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1158\/0008-5472.CAN-07-1083","article-title":"The let-7 microRNA represses cell proliferation pathways in human cells","volume":"67","author":"Johnson","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2024.155222_bib22","article-title":"Anticancer activity of NF\u03baB decoy oligonucleotide-loaded nanoparticles against human lung cancer","volume":"82","author":"Kannaujiya","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.prp.2024.155222_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112951","article-title":"Biomedical applications of metallic nanoparticles in cancer: current status and future perspectives","volume":"150","author":"Khursheed","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.prp.2024.155222_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(03)00801-8","article-title":"Functional siRNAs and miRNAs exhibit strand bias","volume":"115","author":"Khvorova","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.prp.2024.155222_bib25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41419-022-04826-5","article-title":"ROR activation by Nobiletin enhances antitumor efficacy via suppression of IkappaB\/NF-kappaB signaling in triple-negative breast cancer","volume":"13","author":"Kim","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2024.155222_bib26","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1158\/0008-5472.CAN-05-0551","article-title":"TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers","volume":"65","author":"Le Calvez","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2024.155222_bib27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"cell"},{"key":"10.1016\/j.prp.2024.155222_bib28","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjc.6605901","article-title":"MicroRNA in lung cancer","volume":"103","author":"Lin","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2024.155222_bib29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/15384047.2017.1281497","article-title":"MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals","volume":"18","author":"Lv","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.prp.2024.155222_bib30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: biogenesis, function and role in cancer","volume":"11","author":"Macfarlane","year":"2010","journal-title":"Curr. Genom."},{"key":"10.1016\/j.prp.2024.155222_bib31","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4155\/fmc-2019-0338","article-title":"Recent advances in experimental animal models of lung cancer","volume":"12","author":"Malyla","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.prp.2024.155222_bib32","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1200\/JCO.2005.08.043","article-title":"EGFR mutations in non\u2013small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment","volume":"23","author":"Marchetti","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155222_bib33","first-page":"987","article-title":"miRNA nanotherapeutics: potential and challenges in respiratory disorders","author":"Mehta","year":"2020","journal-title":"Future Sci."},{"key":"10.1016\/j.prp.2024.155222_bib34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10787-020-00698-3","article-title":"Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update","volume":"28","author":"Mehta","year":"2020","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.prp.2024.155222_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13954","article-title":"Berberine loaded liquid crystalline nanostructure inhibits cancer progression in adenocarcinomic human alveolar basal epithelial cells in vitro","volume":"45","author":"Mehta","year":"2021","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.prp.2024.155222_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2020.102303","article-title":"Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: current status and future perspectives","volume":"31","author":"Mehta","year":"2021","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"key":"10.1016\/j.prp.2024.155222_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.47","article-title":"Mir-34: a new weapon against cancer?","volume":"3","author":"Misso","year":"2014","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.prp.2024.155222_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118524","article-title":"Pulmonary delivery of nanocomposite microparticles (NCMPs) incorporating miR-146a for treatment of COPD","volume":"569","author":"Mohamed","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.prp.2024.155222_bib39","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1158\/1078-0432.CCR-06-2077","article-title":"Implication of the insulin-like growth factor-IR pathway in the resistance of non\u2013small cell lung cancer cells to treatment with gefitinib","volume":"13","author":"Morgillo","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2024.155222_bib40","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jconrel.2023.12.012","article-title":"Nebulised delivery of RNA formulations to the lungs: from aerosol to cytosol","volume":"366","author":"Neary","year":"2024","journal-title":"J. Control Release"},{"key":"10.1016\/j.prp.2024.155222_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2024.155222_bib42","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1126\/science.1178705","article-title":"A high-resolution structure of the pre-microRNA nuclear export machinery","volume":"326","author":"Okada","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.prp.2024.155222_bib43","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gad.233585.113","article-title":"A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression","volume":"28","author":"Okada","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2024.155222_bib44","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ptr.5784","article-title":"Anticancer activity of Punica granatum (Pomegranate): a review","volume":"31","author":"Panth","year":"2017","journal-title":"Phytother. Res"},{"key":"10.1016\/j.prp.2024.155222_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13122008","article-title":"Recent advances in chronotherapy targeting respiratory diseases","volume":"13","author":"Paudel","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.prp.2024.155222_bib46","series-title":"Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems","first-page":"493","article-title":"Targeting lung cancer using advanced drug delivery systems","author":"Paudel","year":"2020"},{"key":"10.1016\/j.prp.2024.155222_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119436","article-title":"Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro","volume":"276","author":"Paudel","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2024.155222_bib48","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2741\/2865","article-title":"Protein interactions and complexes in human microRNA biogenesis and function","volume":"13","author":"Perron","year":"2008","journal-title":"Front. Biosci.: J. Virtual Libr."},{"key":"10.1016\/j.prp.2024.155222_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109125","article-title":"Plants derived therapeutic strategies targeting chronic respiratory diseases: chemical and immunological perspective","volume":"325","author":"Prasher","year":"2020","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.prp.2024.155222_bib50","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/jcmm.12889","article-title":"miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor","volume":"20","author":"Qin","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.prp.2024.155222_bib51","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0140-6736(15)01125-3","article-title":"Large-scale screening for somatic mutations in lung cancer","volume":"387","author":"Rosell","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2024.155222_bib52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.prp.2024.155222_bib53","doi-asserted-by":"crossref","first-page":"1260411","DOI":"10.3389\/fonc.2023.1260411","article-title":"Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions","volume":"13","author":"Sahu","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2024.155222_bib54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.med.54.101601.152202","article-title":"Molecular genetics of lung cancer","volume":"54","author":"Sekido","year":"2003","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.prp.2024.155222_bib55","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1111\/1759-7714.13678","article-title":"MiR-133a acts as a tumor suppressor in lung cancer progression by regulating the LASP1 and TGF-\u03b2\/Smad3 signaling pathway","volume":"11","author":"Shen","year":"2020","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.prp.2024.155222_bib56","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/jnci\/dji055","article-title":"Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers","volume":"97","author":"Shigematsu","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2024.155222_bib57","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nrc2190","article-title":"Lung cancer in never smokers\u2014a different disease","volume":"7","author":"Sun","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2024.155222_bib58","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.prp.2024.155222_bib59","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-04-0637","article-title":"Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival","volume":"64","author":"Takamizawa","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2024.155222_bib60","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00161-2018","article-title":"Nebulised lipid\u2013polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells","volume":"5","author":"Vencken","year":"2019","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.prp.2024.155222_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13572","article-title":"Anti-inflammatory and anticancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro","volume":"45","author":"Wadhwa","year":"2021","journal-title":"J. Food Biochem"},{"key":"10.1016\/j.prp.2024.155222_bib62","first-page":"1","article-title":"Epigenetic therapy as a potential approach for targeting oxidative stress\u2013induced non-small-cell lung cancer","author":"Wadhwa","year":"2020","journal-title":"Handb. Oxid. Stress Cancer.: Mech. Asp."},{"key":"10.1016\/j.prp.2024.155222_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-015-0210-9","article-title":"Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation","volume":"8","author":"Wang","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2024.155222_bib64","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3727\/096504016X14685034103194","article-title":"MicroRNA-16-1 inhibits tumor cell proliferation and induces apoptosis in A549 non-small cell lung carcinoma cells","volume":"24","author":"Wang","year":"2016","journal-title":"Oncol. Res."},{"key":"10.1016\/j.prp.2024.155222_bib65","article-title":"Quantification and dynamic monitoring of EGFR T790M in plasma cell-free DNA by digital PCR for prognosis of EGFR-TKI treatment in advanced NSCLC","volume":"9","author":"Wang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2024.155222_bib66","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(93)90530-4","article-title":"Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans","volume":"75","author":"Wightman","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.prp.2024.155222_bib67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0163-7258(98)00045-X","article-title":"The epidermal growth factor receptor and its inhibition in cancer therapy","volume":"82","author":"Woodburn","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.prp.2024.155222_bib68","doi-asserted-by":"crossref","first-page":"15163","DOI":"10.1073\/pnas.1006432107","article-title":"Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.prp.2024.155222_bib69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nsmb.1733","article-title":"ATP-dependent human RISC assembly pathways","volume":"17","author":"Yoda","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.prp.2024.155222_bib70","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jtcvs.2012.06.030","article-title":"The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non\u2013small cell lung cancer","volume":"144","author":"Yoon","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.prp.2024.155222_bib71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2004.06.017","article-title":"Single processing center models for human Dicer and bacterial RNase III","volume":"118","author":"Zhang","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.prp.2024.155222_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2022.13499","article-title":"miR\u201129a\u20113p inhibits the malignant characteristics of non\u2011small cell lung cancer cells by reducing the activity of the Wnt\/\u03b2\u2011catenin signaling pathway","volume":"24","author":"Zhang","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2024.155222_bib73","doi-asserted-by":"crossref","first-page":"2100629","DOI":"10.1002\/advs.202100629","article-title":"Pulmonary aerosol delivery of Let-7b microRNA confers a striking inhibitory effect on lung carcinogenesis through targeting the tumor immune microenvironment","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.prp.2024.155222_bib74","article-title":"Aerosolized miR-138-5p and miR-200c targets PD-L1 for lung cancer prevention","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2024.155222_bib75","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317697579","article-title":"MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3","volume":"39","author":"Zhong","year":"2017","journal-title":"Tumor Biol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382400133X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382400133X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T08:57:17Z","timestamp":1731401837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382400133X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":75,"alternative-id":["S034403382400133X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155222","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155222"}}